Modular branched endoprosthesis systems, devices and methods - Patents.com
The method of deploying expandable devices with a portal for connecting to branch vessels addresses the challenge of delivering modular endoprosthesis systems in complex vascular anatomy, ensuring effective antegrade and retrograde blood flow for vascular disease treatment.
Patent Information
- Application Number
- JP2021549816
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-02-26
- Filing Date
- 2020-02-26
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2040-02-26
AI Technical Summary
Current devices and methods for endoluminal treatment of vascular diseases at branch vessel and main vessel junctions, such as those affecting the aorta, celiac artery, and superior mesenteric artery, lack effective systems for delivering modular bifurcated vascular endoprosthesis systems.
A method involving expandable devices configured to be deployed in a main blood vessel, with a second device having a portal for connecting to a branch vessel, allowing for retrograde perfusion through a branch guidewire, and sequential deployment of these devices to form a fluid connection, enabling modular endoprosthesis assembly in the vasculature.
Enables efficient delivery and deployment of modular endoprosthesis systems in complex vascular anatomy, providing antegrade and retrograde blood flow to branch vessels, enhancing treatment efficacy for vascular diseases.
Smart Images

Figure 0007582955000001 
Figure 0007582955000002 
Figure 0007582955000003
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of Provisional Application No. 62 / 810,736, filed February 26, 2019, which is incorporated by reference in its entirety for all purposes.
[0002] Field The present disclosure relates to a delivery system and method for endoluminal delivery of a modular branched vascular endoprosthesis system to a vascular treatment site. [Background technology]
[0003] background There is a need for advanced devices, tools, systems and methods for use in the endoluminal treatment of vascular disease in the region of branch vessels and main vessel junctions, including disease affecting the aorta, including the celiac artery, superior mesenteric artery, and the descending aorta adjacent to the two renal arteries. Summary of the Invention
[0004] Abstract According to one example ("Example 1"), a method includes providing a first expandable device configured to be deployed in a main blood vessel; providing a second expandable device configured to interface with the first expandable device, where the second expandable device includes a portal therein; providing a branch vessel expandable device configured to form a fluid connection between a branch vessel and the second expandable device via the portal once expanded; placing a branch guidewire into the branch vessel; and, while maintained in a fully undeployed state, placing the branch vessel expandable device over the branch guidewire into the branch vessel. positioning and deploying the first expandable device within the main blood vessel, where the branch vessel expandable device is positioned external to the first expandable device; positioning and deploying the second expandable device downstream of the branch vessel, where the branch guidewire and the branch vessel expandable device each extend through a portal of the second expandable device; and deploying the branch vessel expandable device such that the branch vessel expandable device is fluidly coupled with the second expandable device via a portal of the second expandable device, where blood is perfused into the branch vessel via retrograde flow.
[0005] According to another example ("Example 2"), further to Example 1, the branch guidewire is placed into a renal artery, the branch vaso-expandable device is placed into the renal artery over the branch guidewire while being maintained in a fully undeployed state, the first expandable device is placed into the patient's aorta and deployed, the branch vaso-expandable device is positioned external to the first expandable device, the second expandable device is placed and deployed at least partially downstream of the renal artery, and the branch guidewire and branch expandable device extend through a portal to form a fluid connection between the renal artery and the second expandable device to provide retrograde perfusion of blood to the renal artery.
[0006] According to another example ("Example 3"), in addition to Example 1, the main vessel is the common iliac artery and the branch vessel is the internal iliac artery.
[0007] According to another example ("Example 4"), in addition to Example 1, the main vessel is the external iliac artery and the branch vessel is the femoral artery.
[0008] According to another example ("Example 5"), in addition to any of the examples, positioning the branch vessel expandable device over the branch guidewire in the branch vessel includes advancing the branch vessel expandable device over the branch guidewire after the second expandable device is deployed.
[0009] According to another example ("Example 6"), in addition to Example 5, the branch vessel expandable device is deployed after the second expandable device is deployed.
[0010] According to another example ("Example 7"), in addition to any of the examples, the branched vessel expandable device is directly coupled to the second expandable device.
[0011] According to another example ("Example 8"), a method includes providing a first expandable device configured to be deployed in a blood vessel; providing a second expandable device configured to interface with the first expandable device, where the second expandable device includes a portal therein; providing a branch expandable device configured to form a fluid connection between a branch vessel and the second expandable device via the portal; positioning a branch guidewire in the branch vessel; positioning and deploying the first expandable device in the main vessel; positioning and deploying the second expandable device downstream of the branch vessel, where the branch guidewire extends through the portal; positioning the branch expandable device over the branch guidewire to interconnect the branch vessel with the second expandable device external to the first expandable device; and deploying the branch expandable device to form a fluid connection between the branch vessel and the second expandable device, where blood is perfused into the branch vessel via retrograde flow.
[0012] According to another example ("Example 9"), in addition to Example 8, the branched guidewire is positioned within a renal artery, and the second expandable device is positioned and deployed at least partially downstream of the renal artery, and the second expandable device is fluidly coupled to the renal artery via the branched expandable device to provide retrograde perfusion of blood to the renal artery.
[0013] According to another example ("Example 10"), in addition to Example 8, the main vessel is a common iliac artery and the branch vessel is an internal iliac artery.
[0014] According to another example ("Example 11"), in addition to Example 8, the main vessel is the external iliac artery and the branch vessel is the femoral artery.
[0015] According to another example ("Example 12"), in addition to any of Examples 8-11, the method further includes deploying a third expandable device between the second expandable device and the branch vessel expandable device.
[0016] According to another example ("Example 13"), in addition to example 12, the third expandable device is advanced into position over the branched guidewire.
[0017] According to another example ("Example 14"), in addition to any of Examples 12 and 13, the third expandable device is deployed after the branch vessel expandable device is deployed and after the second expandable device is deployed.
[0018] According to another example ("Example 15"), in addition to any of the examples above, the second expandable device is provided in a collapsed delivery configuration, and a removable guidewire tube extends through the portal to enable insertion of the branched guidewire therethrough.
[0019] According to another example ("Example 16"), in addition to Example 15, the method further includes removing the removable guidewire tube after inserting the second guidewire through the removable guidewire tube.
[0020] According to another example ("Example 17"), in addition to Example 16, the method further includes removing the removable guidewire tube prior to inserting the second expandable device into the main blood vessel.
[0021] According to another example ("Example 18"), in addition to any of the examples above, the first expandable device and the second expandable device are deployed prior to deploying the branch vessel expandable device.
[0022] According to another example ("Example 19"), in addition to any of Examples 8-17, the branched vessel expandable device is deployed before the second expandable device is deployed.
[0023] According to another example ("Example 20"), in addition to any of Examples 1-18, the branched vessel expandable device is deployed after the second expandable device is deployed.
[0024] According to another example ("Example 21"), in addition to any of the examples above, the second expandable device is deployed after the first expandable device is deployed.
[0025] According to another example ("Example 22"), in addition to any of the examples above, each of the first expandable device, the second expandable device, and the branch expandable device are advanced from a first access site downstream of the branch vessel.
[0026] According to another example ("Example 23"), in addition to any of the examples above, the branched vessel expandable device is fluidly coupled to the second expandable device via the portal.
[0027] According to another example ("Example 24"), in addition to any of the examples above, the first expandable device is advanced over a separate first guidewire that is distinct from the branch guidewire.
[0028] According to another example ("Example 25"), in addition to Example 24, the second expandable device is advanced over each of the first guidewire and the branch guidewire.
[0029] According to another example ("Example 26"), in addition to any of the examples above, the portal is disposed in a sidewall of the second expandable device.
[0030] According to another example ("Example 27"), an expandable device configured to repair a main blood vessel extending from an upstream end to a downstream end includes a first expandable device configured to be deployed within a blood vessel, a second expandable device configured to interface with the first expandable device, the second expandable device including a portal in a sidewall of the second expandable device, and a branch vessel expandable device configured to extend through the portal to form a fluid connection between a branch vessel and the second expandable device, wherein the branch expandable device is configured to have a length sufficient to cooperate with the second expandable device implanted downstream of the branch vessel to enable retrograde perfusion into the branch vessel through the branch vessel expandable device.
[0031] According to another example ("Example 28"), further to Example 27, the branch vessel expandable device is configured to have a radial expansion force sufficient to maintain significant flow therethrough when deployed outside of the first expandable device between the first expandable device and a wall of the main vessel.
[0032] According to another example ("Example 29"), in addition to any of Examples 27-28, the branched vessel expandable device is directly coupled to the second expandable device.
[0033] According to another example ("Example 30"), in addition to any of Examples 27-28, the device further includes a third expandable device extending between the second expandable device and the branch vessel expandable device, the third expandable device configured to enable retrograde perfusion to the branch vessel through the branch vessel expandable device and the third expandable device.
[0034] According to another example ("Example 31"), in addition to any of Examples 27-30, the sidewall of the second expandable device includes a recessed portion recessed relative to the sidewall, and the portal is located in the recessed portion.
[0035] According to another example ("Example 32"), in addition to any of Examples 27-30, the device further includes a downstream expandable device extending from the second expandable component and fluidly coupling the second expandable component to one or more blood vessels downstream of the second expandable component.
[0036] According to another example ("Example 33"), in addition to any of Examples 27-30, the first expandable device includes a body portion, a first leg and a second leg branching from the body portion, and the second expandable device is configured to interface with one of the first leg and the second leg of the first expandable device.
[0037] According to another example ("Example 34"), further to Example 33, the first leg and the second leg are structurally biased at an angle away from each other.
[0038] According to another example ("Example 35"), in addition to any of Examples 33 to 34, the second expandable device is First leg and further comprising an additional second expandable device configured to interface with a second leg of the first expandable device, the additional second expandable device configured to interface with a second leg of the first expandable device and including a portal in a sidewall of the second expandable device.
[0039] According to another example ("Example 36"), in addition to Example 35, the device also includes an additional branch vessel expandable device configured to extend through the portal to form a fluid connection between a second branch vessel and the additional second expandable device.
[0040] According to another example ("Example 37"), in addition to any of Examples 27-36, the second expandable component includes a proximal end and a distal end, and a tapered configuration, wherein the proximal end has a smaller diameter than the distal end.
[0041] According to another example ("Example 38"), in addition to any of Examples 27-37, the portal of the second expandable device is an aperture in a sidewall of the second expandable device.
[0042] According to another example ("Example 39"), in addition to any of Examples 27-38, the device also comprises the second expandable device and Branching vessels A bridge expandable component configured to be disposed between the expandable device.
[0043] According to another example ("Example 40"), further to the above-mentioned example 39, the bridge expandable component has a first end coupled to a portal of the second expandable component; Branch vessel dilatation possible The component is configured to deploy with the second end coupled thereto.
[0044] According to another example ("Example 41"), in addition to any of Examples 40, the branched vascular expandable component includes one or more tissue anchors for engaging tissue.
[0045] While multiple embodiments are disclosed, still other embodiments will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative examples. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive. [Brief description of the drawings]
[0046] BRIEF DESCRIPTION OF THE DRAWINGS The features and advantages of the present disclosure will become more apparent from the following detailed description when taken in conjunction with the drawings.
[0047] [Figure 1] FIG. 1 is a cross-sectional view of the human anatomy showing the aorta, including the two renal arteries and the two iliac arteries.
[0048] [Diagram 2]FIG. 2 is a cross-sectional view of the human anatomy of FIG. 1 showing a modular endoprosthetic system implanted therein, according to some embodiments.
[0049] [Diagram 3] FIG. 3 shows a main vascular expandable component in the form of a bifurcated expandable endoprosthesis, according to some embodiments.
[0050] [Figure 4] FIG. 4 shows a branched vascular expandable component, according to some embodiments.
[0051] [Figure 5A] FIG. 5A illustrates a portal extensible component according to some embodiments.
[0052] [Figure 5B] FIG. 5B illustrates the portal expandable component of FIG. 5A with a branch vessel expandable component coupled thereto, according to some embodiments.
[0053] [Figure 6] FIG. 6 illustrates a portal expandable component having a removable guidewire tube extending therethrough, according to some embodiments.
[0054] [Figure 7] FIG. 7 illustrates the portal-expandable component of FIG. 6 in a constrained, collapsed delivery configuration, according to some embodiments.
[0055] [Figure 8] FIG. 8 illustrates a method of delivering a modular endoprosthesis system, according to some embodiments.
[0056] [Figure 9A]FIG. 9A is a cross-sectional view of the human anatomy with a guidewire extending through a lower access site, crossing a main vessel, and extending into a branch vessel.
[0057] [Figure 9B] FIG. 9B is a detailed view of the cross-sectional view of the human anatomy of FIG. 9A, showing a branch vessel expandable device in a constrained and collapsed delivery configuration positioned within a branch vessel, according to some embodiments.
[0058] [Figure 9C] FIG. 9C is a detailed view of the cross-sectional view of the human anatomy of FIG. 9B, with a second guidewire positioned within the human anatomy in the region of the branched vasoexpandable device, according to some embodiments.
[0059] [Figure 9D] FIG. 9D is a cross-sectional view of the human anatomy of FIG. 9A with the main vessel expandable device fully deployed within the main vessel, according to some embodiments.
[0060] [Figure 9E] FIG. 9E is a cross-sectional view of the human anatomy of FIG. 9D with an additional expandable component deployed within the anatomy, according to some embodiments.
[0061] [Figure 10] FIG. 10 illustrates a subset of steps corresponding to a method of delivering the modular endoprosthesis system of FIG. 8, according to some embodiments.
[0062] [Figure 11] FIG. 11 is a cross-sectional view of the human anatomy with a main vessel expandable device and a portal expandable device deployed in a main vessel and a branch vessel expandable device deployed in a branch vessel, according to some embodiments.
[0063] [Figure 12]FIG. 12 is a cross-sectional view of the human anatomy of FIG. 11 showing a guidewire extending through the portal expandable component and the branch vessel expandable component, according to some embodiments.
[0064] [Figure 13] FIG. 13 is a cross-sectional view of the human anatomy of FIG. 12, according to some embodiments, with the bridge expandable component deployed and extending between the portal expandable component and the branch vessel expandable component.
[0065] [Figure 14] FIG. 14 illustrates a method of delivering a modular endoprosthesis system, according to some embodiments.
[0066] [Figure 15] FIG. 15 is a cross-sectional view of the human anatomy with multiple guidewires extending through a lower access site and into the anatomy, according to some embodiments.
[0067] [Figure 16] FIG. 16 is a cross-sectional view of the human anatomy of FIG. 15 showing a main vessel expandable device deployed within the main vessel, according to some embodiments.
[0068] [Figure 17] FIG. 17 is a cross-sectional view of the human anatomy of FIG. 16 , according to some embodiments, showing the portal expandable component in a constrained, collapsed delivery configuration being advanced along a guidewire toward a desired location within the human anatomy.
[0069] [Figure 18] FIG. 18 is a cross-sectional view of the human anatomy of FIG. 17 with the portal expandable component deployed, according to some embodiments.
[0070] [Figure 19]FIG. 19 is a cross-sectional view of the human anatomy of FIG. 18 with the branched vasculature expandable component advanced in a constrained, collapsed delivery configuration, according to some embodiments.
[0071] [Figure 20] FIG. 20 is a cross-sectional view of the human anatomy of FIG. 19 with the main vessel expandable component, the portal expandable component and the branch vessel expandable component fully expanded, according to some embodiments. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0072] Detailed Description Those skilled in the art will readily appreciate that the various aspects of the present disclosure may be realized through a variety of methods and devices configured to perform the intended functions. It should also be noted that the accompanying drawings referred to herein are not all drawn to scale and may be exaggerated to illustrate various aspects of the present disclosure, and in that respect the drawings should not be construed as limiting. Finally, the present disclosure may be described in conjunction with various principles and beliefs, but the present disclosure should not be bound by theory.
[0073] Throughout this specification and in the claims, the term "distal" refers to a location that is further downstream in terms of blood flow when implanted, or to a portion of a device that is downstream from another portion of an intraluminal device (e.g., a stent graft). Similarly, the term "distally" refers to the direction of blood flow, or further downstream in the direction of blood flow.
[0074] The term "proximal" refers to a location that is further upstream with respect to blood flow when implanted, or a portion of the device that is upstream from another portion of the endoluminal device. Similarly, the term "proximally" refers to a direction against or upstream from the direction of blood flow.
[0075] Further with respect to the terms proximal and distal, and as the present disclosure is not limited to peripheral and / or central approaches, this disclosure should not be construed narrowly with respect to these terms, rather, the devices and methods described herein can be modified and / or tailored in relation to the patient's anatomy.
[0076] In some embodiments, the devices and systems described herein can be configured to be used retrogradely, i.e., delivered to a target site in a direction against the direction of blood flow, or to be used antegradely, i.e., the device is delivered to a target site in the direction of blood flow.
[0077] Devices, systems and methods for intraluminally delivering a modular endoprosthesis system according to various embodiments are disclosed herein for treating diseases of the human vasculature. In various embodiments, the modular endoprosthesis system includes a plurality of expandable endoprosthesis components that are coupled together to define the modular endoprosthesis system, as described further below. FIG. 1 shows a vasculature including an aorta 100 having a descending aorta 102, renal arteries 104 and 106, and iliac arteries 108 and 110. The aorta 100 includes an abdominal aortic aneurysm 112 downstream of the renal arteries 104 and 106. It will be understood that the location and configuration of the abdominal aortic aneurysm 112 is not intended to limit the scope or applicability of the disclosure of the modular endoprosthesis system described herein. The modular endoprosthesis system described herein is broadly applicable to vascular diseases involving the treatment of main and branch vessels.
[0078] Thus, although the description and figures of the present application are shown in the context of treating the aorta 100, including the descending aorta 102 shown in Figure 1, it should be understood that the devices, systems, and methods of the present disclosure may be applied to treat other portions of the vasculature, including, for example, larger vessels and any disease in which one or more branch vessels are to be treated. Such treatments may include treatments that involve regions within the vasculature that include one or more branch vessels, and thus may require main vascular endoprosthesis components that include branched or non-branched configurations.
[0079] In various embodiments, the modular endoprosthesis systems of the present disclosure include multiple expandable endoprosthesis components, such as stents and stent-grafts, that are assembled together to collectively form or otherwise define a modular endoprosthesis. That is, in various examples, a modular endoprosthesis includes multiple distinct and independent expandable endoprosthesis components that are configured to interface with other distinct and independent expandable endoprosthesis components. The modular configuration provides versatility in how and where the modular endoprosthesis can be used and in what configurations it is used.
[0080] 2, for example, a modular endoprosthesis system 200 is shown implanted within the vasculature. As shown, the modular endoprosthesis system 200 includes a first or main vessel expandable component 300, a branch vessel expandable component 400, and a second or portal expandable component 500. When fully assembled and deployed, each of the main vessel expandable component 300, the branch vessel expandable component 400, and the portal expandable component 500 are fluidly coupled together. Thus, blood entering the main vessel expandable component 300 can perfuse through the portal expandable component 500 to the branch vessel component 400. As shown, blood entering the main vessel expandable component 300 propagates through the main vessel expandable component 300 and the portal expandable component 500 via antegrade flow and propagates to the branch vessels 104 and 106 via retrograde flow through the branch vessel component 400. This is because blood flow exiting the portal expandable component 500 and flowing toward the branch vessels 104 and 106 exits the portal expandable component 500 downstream of the branch vessels 104 and 106. In various examples, as discussed further below, each and all of the various expandable components that collectively define the modular endoprosthesis system 200 can be delivered to a treatment site within the vasculature from the same access site. This access site can be an upper or lower access site relative to the treatment area. Thus, it should be understood that each and all of the various expandable components that collectively define the modular endoprosthesis system 200 can be delivered and deployed to a treatment site via retrograde delivery (e.g., through a femoral access).
[0081] Optional elements, bridge expandable components 600, are also shown in FIG. 2, although they are not required, as will be explained further below, as are one or more downstream expandable components 700.
[0082] In various examples, modular endoprosthesis system 200 is configured such that assembly and / or deployment of the various components can occur in situ. Thus, assembly and / or deployment of the various components of modular endoprosthesis system 200 can include sequential delivery and deployment of the various components instead of a single non-modular deployment sequence. Thus, one or more expandable components of modular endoprosthesis system 200 can be delivered and fully deployed within the vasculature before another one of the expandable components is inserted into the vasculature or delivered to a treatment site.
[0083] The modular expandable components of the present disclosure can include one or more modular stents or stent-graft components, and thus can generally include one or more of a support component or element and a graft component or element, as discussed further below. These expandable components (also referred to as modular stents and / or stent-graft components) can be configured to expand from a delivery configuration, through a series of larger intermediate configurations, toward a deployed configuration. The expandable components can be configured to engage with each other and / or with one or more portions of the vasculature, such as the vessel wall at the treatment site. The expandable components can have a variety of configurations, such as, for example, rings, cut tubes, wound wires (or ribbons), or flat patterned sheets rolled into a tubular form. In some examples, the stent and / or stent-graft components can include metals, polymers, or natural materials, including conventional medical grade materials such as metals such as nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, polytetrafluoroethylene, polytrifluorochloroethylene, polyvinyl chloride, polyurethane, elastomeric organosilicon polymers, stainless steel, cobalt chromium alloys, and nitinol, and biologically derived materials such as bovine arteries / veins, pericardium, collagen, etc. In some examples, the stent and / or stent-graft components can include bioabsorbable materials such as poly(amino acids), poly(anhydrides), poly(caprolactone), poly(lactic / glycolic acid) polymers, poly(hydroxybutyrates), and poly(orthoesters).
[0084] In various embodiments, potential non-limiting materials for the graft element include, for example, expanded polytetrafluoroethylene (ePTFE), polyester, polyurethane, perfluoroelastomer, fluoropolymers such as polytetrafluoroethylene, silicone, urethane, ultra-high molecular weight polyethylene, aramid fibers, and combinations thereof. The graft element material may additionally or alternatively include high strength polymer fibers such as ultra-high molecular weight polyethylene fibers (e.g., Spectra®, Dyneema Purity®, etc.) or aramid fibers (e.g., Technora®, etc.). Any graft element that can be delivered via a catheter is in accordance with the present disclosure. In some instances, the graft element may include a bioactive agent. In some instances, the ePTFE graft includes a carbon component along its blood-contacting surface. Further details of the materials and general construction of stents, graft elements and stent grafts generally are disclosed in US Pat. Nos. 6,042,605, 6,361,637 and 6,520,986 (all to Martin et al.).
[0085] In various embodiments, the support component and / or graft component can include a therapeutic coating. In these embodiments, the interior and / or exterior of the support component and / or graft component can be coated with, for example, a CD34 antigen. Additionally, the graft component can be coated with any number of drugs or therapeutic agents, including, for example, heparin, sirolimus, paclitaxel, everolimus, ABT-578, mycophenolic acid, tacrolimus, estradiol, oxygen free radical scavengers, biolimus A9, anti-CD34 antibodies, PDGF receptor blockers, MMP-1 receptor blockers, VEGF, G-CSF, HMG-CoA reductase inhibitors, stimulators of iNOS and eNOS, ACE inhibitors, ARBs, doxycycline, thalidomide, and the like, among others.
[0086] Consistent with the above description of the versatility of the devices, systems, and methods described herein, while the modular endoprosthesis system 200 shown in FIG. 2 includes a branched main vessel expandable component 300, a non-branched expandable component can be used in applications where a branched component is not required. For example, a non-branched main vessel expandable component can be used in applications where dedicated perfusion from a main vessel component to multiple branch vessels is not required. "AUI" (Aorto-uni-iliac) treatment generally involves supplying blood to only one iliac artery directly from the abdominal aorta, since the second iliac artery may already be occluded or declared unsalvageable by a physician. In some instances, a physician may use, for example, a portal expandable component 500 in combination with the main vessel expandable component 300 and the branched vessel expandable component 400, while not effectively perfusing the other iliac artery directly from the abdominal aorta. Instead, perfusion of the second iliac artery is achieved by a surgical bypass graft that extends directly between the patient's external iliac artery or femoral artery.
[0087] As shown in FIG. 2, in various embodiments, the modular endoprosthesis system 200 can include additional expandable components based on the anatomy and the needs of the particular vascular treatment being performed. The modular endoprosthesis system 200 includes, for example, an optional bridge expandable endoprosthesis 208 configured to extend between and fluidly couple the portal expandable component 500 and the branch vessel expandable component 400. In some instances, the bridge expandable endoprosthesis 600 is utilized to increase the distance between the portal expandable component 500 and the branch vessel expandable component 400, which may be required based on the particular configuration of the patient's anatomy and / or as a result of the particular delivery sequence being used. The modular endoprosthesis system 200 shown in FIG. 2 also includes downstream expandable components 700, one or more of which may be used to optionally fluidly couple the portal expandable component 500 to one or more blood vessels downstream of the portal expandable component 500.
[0088] 3-5 show some of the various expandable components of the modular endoprosthesis system 200. For example, FIG. 3 shows a main vascular expandable component 300 including a support component 302 and a graft component 304. The main vascular expandable component 300 is shown in FIGS. 2 and 3 as a branched endoprosthesis, although non-branched endoprosthesis configurations are contemplated, as noted above. The main vascular expandable component 300 includes a body portion 306 (also referred to as a trunk portion), a contralateral leg 308 (also referred to herein as a first leg or a second leg), and an ipsilateral leg 310 (also referred to herein as a second leg or a first leg, depending on the designation of the contralateral leg 308). In various examples, the main vascular expandable component 300 provides a collapsed delivery configuration for endoluminal delivery and an expanded configuration that is larger than the collapsed delivery configuration.
[0089] In various examples, graft component 304 is generally any extraluminal (i.e., outer vascular surface) or luminal (i.e., inner blood flow surface) covering configured to partially or substantially cover one or more support components. In various embodiments, graft components such as graft component 304 include ePTFE. However, other useful materials for graft components can include one or more of nylon, polycarbonate, polyethylene, polypropylene, polytetrafluoroethylene, polyvinyl chloride, polyurethane, polysiloxane, and other biocompatible materials, or any of the other graft component materials listed above.
[0090] In various examples, the graft component 304 is securely affixed or otherwise bonded to the abluminal or luminal surface of the support component at single or multiple locations, for example, using one or more of taping, heat shrinking, adhesives, and other methods known in the art. In some embodiments, multiple graft components can be used and bonded to both the abluminal and luminal surfaces of the support component. In other embodiments, multiple graft components "sandwich" the support component, with the graft components attached to each other within the voids of the support component.
[0091] In various embodiments, the support component 302 (also referred to as a stent component) provides structural support for the main vessel expandable component graft component 304 and / or the vasculature being treated. The support component 302 can be a stent including a wire including a helical configuration, or can include one or more rings. Among other configurations, the wire or rings themselves can be linear or have a sinusoidal or zigzag pattern. In some instances, the support component 302 is cut from a tube and can have any pattern suitable for the treatment.
[0092] The support component 302 can include a shape memory material such as Nitinol, however, in other embodiments, the support component 302 can include other materials that are self-expandable or otherwise expandable (e.g., with a conventional balloon catheter or spring mechanism), such as various metals (e.g., stainless steel), alloys, and polymers.
[0093] In various examples, the cross-section of one or more of the body portions 306 and the first and second legs 308 and 310 can be circular, oval, or polygonal in shape with or without curved features. These cross-sectional shapes can also be either substantially constant or variable along their respective axial lengths. For example, in branched endoprosthesis embodiments, the cross-section of the body portion 306 can be substantially circular at its distal end, but taper to have an oval rectangular cross-section with a smaller cross-sectional area in its branch region adjacent the first and second legs 308 and 310.
[0094] The first and second legs 308 and 310 are generally shown as branching off from and in intraluminal communication with the body portion 306. As shown, each of the first and second legs includes a first end connected to or otherwise integral with an end of the body portion 306, and a second end extending away from the body portion 306 and the first end. The first and second ends 308 and 310 may also be structurally biased at an angle away from each other, such as in a Y-configuration, to face or point toward the respective vessels being treated. The structural bias may come from either or both of the graft component 304 and the support component 302. Additionally, as shown, the axial lengths of the first and second legs 308 and 310 may be the same or different. In various examples, the end of the body portion 306 opposite the end of the body portion 306 to which the first and second legs 308 and 310 are coupled defines the proximal end 312 of the main vessel expandable component 300, while one or more of the ends of the first and second legs 308 and 310 opposite the ends of the first and second legs 308 and 310 coupled to the body portion 306 defines the distal end 314 of the main vessel expandable component 300. In some examples, the proximal end 312 of the main vessel expandable component 300 is configured to anchor against or to the vasculature, such as a vessel wall, while the distal end 314 is configured to interface with one or more other expandable components, as discussed further below. In some examples, the proximal end 312 may be configured to interface with one or more other expandable components. Suitable examples of main vaso-expandable components, including branch vaso-expandable components, can be found in U.S. Pat. Nos. 7,682,380, 8,474,120, 8,945,200, 8,267,988 and 9,827,118.
[0095] As shown in FIG. 4, the branch vasculature expandable component 400 generally includes a support component 402 and a graft component 404. The branch vasculature expandable component 400 includes a proximal end 406 and a distal end 408 and can have a tapered or non-tapered configuration. The proximal and distal ends 406 and 408 can be configured to interface with one or more other expandable components of the modular endoprosthesis system 200. In some examples, one or more other expandable components of the modular endoprosthesis system 200 can be deployed within the lumen of the branch vasculature expandable component 400 at the proximal and / or distal ends 406 and 408. Thus, in some examples, the branch vasculature expandable component 400 can be configured to accommodate deployment of another expandable component within the lumen of the branch vasculature expandable component at the proximal and / or distal ends 406 and 408. Additionally or alternatively, the branch vascular expandable component 400 can be configured such that one or more of its proximal and distal ends 406 and 408 can be deployed within the lumen of another expandable component of the modular endoprosthesis system 200.
[0096] The support component 402 and the graft component 404 can be of similar structure to the support and graft components 302 and 304 described above and can be coupled to each other in any suitable manner known in the art, including those described above. In various examples, the branch vascular expandable component 400 provides a collapsed delivery configuration for intraluminal delivery and an expanded deployed configuration that is larger (e.g., larger in diameter and / or length) than the collapsed delivery configuration. Suitable examples of branch vascular expandable components can be found in U.S. Publication No. 2016 / 0143759, filed November 24, 2015, to Bohn et al., entitled "BALLOON EXPANDABLE ENDOPROSTHESIS."
[0097] As shown in FIG. 5A, the portal expandable component 500 includes a body 502 having a main lumen 504. The body 502 of the portal expandable component 500 has opposing first and second ends 506 and 508 and a wall 510 extending generally longitudinally between the first and second ends 506 and 508. The portal expandable component may be tapered or non-tapered. The wall 510 has an inner surface 512 that defines the main lumen 504. The wall 510 also has an outer surface 514 opposite the inner surface 512. Consistent with the above discussion regarding the main vessel expandable component 300 and the branch vessel expandable component 400, the portal expandable component 500 can include support and graft components (not shown for purposes of clarity, see, e.g., FIG. 6). In some instances, the wall 510 is defined by one or more support and graft components of the portal expandable component 500. Thus, the support and graft components of the portal expandable component 500 can be of similar structure to the support and graft components of the main vessel expandable component 300 and the branch vessel expandable component 400 described above, and can be coupled to one another in any suitable manner, including those described above. In various examples, the portal expandable component 500 provides a collapsed delivery configuration for endoluminal delivery, and an expanded configuration that is larger than the collapsed delivery configuration. Additionally, similar to the branch vessel expandable component 400, the portal expandable component 500 can be configured to interface with one or more other expandable components at its first and second ends 506 and 508.
[0098] In various examples, the portal-expandable component 500 includes at least one portal 516 disposed along a wall 510 between the first and second ends 506 and 508 of the portal-expandable component 500. In various examples, the portal 516 is defined as an opening 518 in the wall 510 exposed to the lumen 504. Thus, the portal 516 provides access to the lumen 504 of the portal-expandable component 500 such that one or more auxiliary expandable components of the modular endoprosthesis system 200 may be fluidly coupled with the lumen 504 of the portal-expandable component 500. For example, as shown in FIG. 2, the branch vessel expandable component 300 is coupled to the portal-expandable component 500 via the portal 516. The portal 516 can include an aperture in the wall 510 of the portal-expandable component 500, although in some other examples, the portal 516 can include alternative configurations.
[0099] For example, in some instances, the wall 510 includes a recessed portion 520 that is recessed relative to an outer surface 514 of the wall 510 and is disposed between the first and second ends 506 and 508 of the body 502. In some such instances, the portal 516 is formed as an opening 518 in the recessed portion 520, as shown in FIG.
[0100] In some examples, the portal 516 can include a reinforced configuration. For example, in some examples, the portal 516 can include one or more support walls, such as support wall 522. The support walls can have any desired length, diameter, wall thickness, or secondary lumen shape, such as oval, polygonal, or "D-shaped". In some examples, the support walls can incorporate a support member, such as a stent, as shown. Additionally or alternatively, the support walls can incorporate a branch member attachment feature, such as a hook anchor, a flared stent apex, or other fastening means commonly known in the art. As shown in FIG. 5A, the support walls 522 extend from each opening 518 toward one of the first and second ends 506 and 508 of the body 502. The support walls 522 thus form a secondary lumen 524 configured to receive one or more auxiliary expandable components of the modular endoprosthesis system 200, such as the branch vascular expandable component 300.
[0101] 5A includes a single portal 516, the portal expandable component 500 may include multiple portals 516, including, for example, multiple support walls 522 and secondary lumens 524, where the multiple support walls may be oriented in approximately the same direction or may be oriented in approximately opposing (non-parallel) directions relative to the longitudinal axis of the portal expandable component 500. For example, in some instances, a first support wall of a first portal may extend toward a first end 506 of the portal expandable component 500, while a second support wall of a second portal extends toward a second end 508 of the portal expandable component 500. In one such instance, the first support wall and secondary lumen having a first orientation thus define a first blood flow direction.
[0102] "Blood flow direction" is defined as the direction defined by blood flow as it enters the secondary lumen defined by the support wall. Conversely, a second support wall and secondary lumen having a second different orientation thus defines a second blood flow direction different from the first blood flow direction. If desired, the first blood flow direction and the second blood flow direction can be oriented between 0° and 180° from each other as needed. Further details regarding internal support wall and portal configurations for supporting branch members extending through openings or portals in the body of an expandable endoprosthesis are disclosed in U.S. Pat. Nos. 6,645,242 and 9,314,328.
[0103] Figure 5B shows the portal expandable component of Figure 5A with a branch vessel expandable component 400 coupled to it via a portal 516 (consistent with the configuration shown in Figure 20). As shown, with the branch vessel expandable component 400 coupled to the portal expandable component 500 via a portal 516, the lumens of the branch vessel expandable component 400 and the portal expandable component 500 are fluidly coupled together.
[0104] As noted above, in some instances, the portal-expandable component can include multiple portals for receiving respective branch vessel components therethrough to direct a portion of blood flow from the lumen of the portal-expandable component to the branch vessel. Such branch portals can be arranged in pairs to face in the same or opposite directions (e.g., proximally, distally, radially outward, at any angle relative to the lumen axis, or any combination thereof, etc.).
[0105] The delivery system and method according to various embodiments disclosed herein can utilize a removable guidewire tube to help facilitate guidewire cannulation after compacting the expandable implant to a delivery configuration for intraluminal delivery to a treatment site. Such a removable guidewire tube can extend through the main lumen of the expandable component, the branch lumen of the expandable component, and / or the portal of the expandable component. As shown in FIG. 6, for example, a first removable guidewire tube 1100 can be inserted through the portal 516 of the portal expandable component 500. Both ends 1102 and 1104 of the removable guidewire tube 1100 can extend axially beyond the first and second ends 506 and 508 of the portal expandable component 500. The removable guidewire tube can include the same materials as described herein for the catheter materials. Further details of the materials and general construction of the removable guidewire tube are described in U.S. Pat. No. 8,273,115 to Hamer et al.
[0106] 7 shows the portal-expandable component 500 in a compacted delivery configuration with a constraining sheath 1200. As shown, the portal-expandable component 500 is coupled to and supported on a delivery catheter 1300. The constraining sheath 1200 extends over the portal-expandable component 500 and releasably constrains it to the compacted delivery configuration. The constraining sheath 1200 can be removed from the portal-expandable component according to known methods. Details of the materials and general construction of the constraining sleeve can be found in U.S. Patent No. 6,352,561 to Leopold et al.
[0107] 7, in the compacted delivery configuration, both ends 1102 and 1104 of the removable guidewire tube 1100 extend beyond the respective ends 1202 and 1204 of the constraining sheath 1200, allowing a guidewire to be routed through the removable guidewire tube 1100 and through the portal 516 of the portal-expandable component 500, even if the portal-expandable component 500 is compressed radially inward or otherwise covered while in the delivery configuration by the constraining sheath 1200. In various embodiments, a method of endoluminal delivery of a modular endoprosthesis can include inserting a first guidewire through an access site and into the vasculature to be treated.
[0108] FIG. 8 is a flow diagram illustrating a method for endoluminal delivery of a modular endoprosthesis according to the present disclosure. As shown in FIG. 8, in step 8002, a first guidewire is advanced through a main vessel into a branch vessel. FIG. 9A illustrates a first guidewire 1000 inserted into a femoral artery through an access site 114, routed through one of the iliac arteries 108 into the descending aorta, and into a first branch vessel 104. As shown in FIG. 9A, a first end 1002 of the first guidewire 1000 is disposed within the first branch vessel 104, while a second end 1004 of the first guidewire 1000 extends to a location outside the patient. Thus, the second end 1004 is accessible from outside the patient's body and can be used to deliver subsequent components of the modular endoprosthesis system 200, as described further below. The placement of the first end 1002 of the first guidewire in the first branch vessel 104 is intended for illustrative purposes only and should not be construed as limiting. Thus, it should be understood that the first end 1002 of the first guidewire 1000 can be placed in any branch vessel from the main vessel in the patient's anatomy and is not limited to the aortic branch vessel. It is also understood that the first guidewire 1000 can be introduced into the anatomy and advanced into the branch vessel according to known methods. The first guidewire 1000 is shown in FIG. 9 as being advanced in a retrograde direction (i.e., against the flow of blood, also referred to as advancing "upstream").
[0109] Referring back to FIG. 8, in step 8004, the branch vessel expandable component is advanced along the first guidewire until it is properly positioned within the branch vessel. The branch vessel expandable component is generally delivered by advancing it along the first guidewire in a radially constrained or compacted delivery configuration, as described above. As shown in FIG. 9B, a cross-sectional detailed view of a patient's anatomy with the branch vessel expandable component in a radially constrained (e.g., by a constraining sheath 1210) and compacted delivery configuration, where the branch vessel expandable component 400 is disposed about a delivery member 1220 (e.g., a catheter). In various examples, proper positioning of the branch vessel expandable component 400 is such that at least a portion of the branch vessel expandable component 400 is disposed within the branch vessel 104 such that when the branch vessel expandable component 400 is expanded to a post-delivery configuration, the branch vessel expandable component 400 is operable to engage the branch vessel (e.g., a blood vessel or tissue wall) and maintain a bond between the branch vessel expandable component 400 and the branch vessel 104.
[0110] Referring back to FIG. 8, at step 8006, a second guidewire is placed within the main vessel. In various examples, the second guidewire is placed within the main vessel in a region proximate to the branch vessel where the branch vessel expandable component is to be disposed. For example, as shown in FIG. 9C, a second guidewire 1050 is placed within the main vessel 100. As shown, the second guidewire 1050 is positioned such that an end 1052 of the second guidewire 1050 is upstream of the branch vessel 104 where the branch vessel expandable component 400 is to be disposed.
[0111] Referring to FIG. 8, in steps 8008 and 8010, the main vessel expandable component is advanced along the second guidewire to a position within the main vessel and then deployed once properly positioned. In various examples, proper positioning of the main vessel expandable component includes positioning the main vessel expandable component such that an end of the main vessel expandable component lands on or otherwise engages the main vessel upstream of the branch vessel in which the branch vessel expandable component is to be positioned. Such a configuration provides that the branch vessel expandable component does not interfere with the end of the main vessel expandable component engaging the vessel wall or tissue surrounding the end of the main vessel expandable component, thereby providing that the main vessel expandable component seals against the main vessel wall without interference from other expandable components. FIG. 9D shows the main vessel expandable device 300 deployed within the main vessel 100 such that the proximal end 312 of the main vessel expandable device 300 engages the vessel wall of the main vessel upstream of the branch vessel 104. Additionally, as shown in FIG. 9D, the distal end 314 of the main vessel expandable component 300 is positioned downstream of the branch vessel 104.
[0112] Referring back to FIG. 8, in steps 8012 and 8014, the portal expandable component is positioned within the main vessel and deployed such that the portal expandable component is fluidly coupled with the main vessel expandable component and the branch vessel expandable component is fluidly coupled with the portal expandable component. FIG. 9E shows the portal expandable component 500 in a deployed configuration, where the portal expandable component 500 is fluidly coupled with the main vessel expandable component 300 (e.g., via legs 308) and the portal expandable component 500 is fluidly coupled with the branch vessel expandable component 400 (e.g., via portal 516) such that the main vessel expandable component 300 is fluidly coupled with the branch vessel expandable component 400. In the configuration shown in FIG. 9E, the portal expandable component 500 is coupled with the main vessel expandable component 300 such that the portal 516 is positioned downstream of the branch vessel 104. As shown, a first end 506 of the portal expandable component 500 is deployed within the lumen of the first leg 308 of the main vessel expandable component 300 at the distal end 314 of the main vessel expandable component 300. With the portal 516 located downstream of the branch vessel 104 in which the branch vessel expandable component 400 is placed, blood flow to the branch vessel via the branch vessel expandable component 400 is retrograde.
[0113] It will be appreciated that similar methods as described above can be performed to deliver and deploy corresponding expandable components to the branch vessels 106 (see, e.g., FIG. 2 for examples involving multiple branch vessels). It will be appreciated that in some examples involving multiple branch vessels (e.g., renal arteries), a branch vessel expandable component is positioned within each branch vessel prior to deployment of the main vessel expandable component.
[0114] As described above, in step 8014, the portal expandable component is deployed such that the portal expandable component is fluidly coupled with the main vessel expandable component and the branch vessel expandable component is fluidly coupled with the portal expandable component. In some instances, the branch vessel expandable component is fluidly coupled with the portal expandable component via a bridge expandable component. The portal expandable component 500 may be coupled with the main vessel expandable component 300 according to known methods. Similarly, the branch vessel expandable component 400 may be coupled with the portal expandable component 500 according to known methods.
[0115] As shown in FIG. 2, the bridge expandable component 600 is disposed between the branch vessel expandable component 400 and the portal expandable component 500. Thus, in various examples, the bridge expandable component 600 is configured to engage with each of the branch vessel expandable component 400 and the portal expandable component 500. The bridge expandable component 600 has a structure consistent with the branch vessel expandable component 400 described above, including, for example, a support component, a graft component, and a first end and a second end with a lumen extending through the first end and the second end. As shown, the bridge expandable component 600 is configured to be delivered to a treatment site and deployed, with the first end coupled to the portal 516 of the portal expandable component 500 and the second end coupled to the branch vessel expandable component 400. In some examples, the branch vessel expandable component 400 includes one or more tissue anchors for engaging tissue (e.g., a vessel wall) of the branch vessel 104.
[0116] In some instances, the bridge expandable component 600 is configured to be deployed at least partially within the lumen of the branch vessel expandable component 400 and at least partially within the portal expandable component 500. In some such instances, the bridge expandable component 600 extends through the portal 516 such that the bridge expandable component 600 is fluidly coupled with the portal expandable component 500.
[0117] FIG. 10 shows a flow chart outlining an exemplary method consistent with step 8014 of FIG. 8 for fluidly coupling the branch vessel expandable component 400 and the portal expandable component 500 via the bridge expandable component 600. In step 8014(A), the portal expandable component is deployed such that the portal expandable component is engaged and fluidly coupled with the main vessel expandable component. FIG. 11 shows the portal expandable component 500 deployed such that the portal expandable component 500 is engaged and fluidly coupled with the main vessel expandable component 300, consistent with the discussion above regarding FIG. 9E. As shown, the portal expandable component 500 is deployed such that the portal 516 is positioned downstream relative to the branch vessel 104. In some instances, the portal expandable component 500 is positioned at least partially within the gate of the main vessel expandable component 300 (e.g., in an overlapping relationship with at least one of the legs 308 and 310 of the main vessel expandable component 300) such that upon deployment of the portal expandable component 500, the portal 516 is fluidly accessible to / coupled to the lumen of the main vessel 100.
[0118] Referring again to FIG. 10, in step 8014(B), the branch vaso-expandable component is deployed. The branch vaso-expandable component may be deployed before or after deploying the portal expandable component. FIG. 11 illustrates the branch vaso-expandable component 400 in a deployed configuration. As shown, the branch vaso-expandable component 400 is deployed such that the first end 406 of the branch vaso-expandable component 400 is disposed in the branch vessel and the second end 408 is disposed in the main vessel. Thus, the portal expandable component 500 is deployed with the portal 516 disposed downstream relative to the first end 406 of the branch vaso-expandable component 400. In some examples, the branch vaso-expandable component 400 may be deployed such that the first and second ends 406 and 408 of the branch vaso-expandable component 400 are disposed in the branch vessel.
[0119] Referring again to Figure 10, in step 8014(C), the bridging guidewire is positioned such that it extends into the lumen of the portal expandable component, through the portal, and into the lumen of the branch vessel expandable component. Figure 12 shows a bridging guidewire 1400 extending from outside the patient's body into the main vessel 100, into the lumen of the portal expandable component 500, through the portal 516, and into the lumen of the branch vessel expandable component 400.
[0120] 10, in steps 8014(D) and 8014(E), the bridge expandable component is advanced to a position extending between the portal expandable component and the branch vessel expandable component and deployed such that the bridge expandable component is fluidly coupled with the portal expandable component and the branch vessel expandable component. The bridge expandable component 600 can be coupled with the branch vessel expandable component 400 and the portal expandable component 500 according to known methods.
[0121] 13 shows the bridge expandable component 600 fluidly coupled to the portal expandable component 500 and the branch vessel expandable component 400. As shown, the bridge expandable component 600 extends from the portal expandable component 500 through the portal 516 and couples to the branch vessel expandable component 400 proximate the second end 408 of the branch vessel expandable component 400. In some instances, the bridge expandable component 600 is deployed such that a portion of the bridge expandable component 600 is disposed within the lumen of the branch vessel expandable component 400. With the main vessel expandable component 300, branch vessel expandable component 400, portal expandable component 500 and bridge expandable component 600 so configured, the modular endoprosthesis system 200 provides that blood flow can be supplied to the branch vessel 104 by retrograde flow through the branch vessel expandable component 400 and the bridge expandable component 600. As noted above, blood propagates through the main vessel expandable component 300 and the portal expandable component 500 by antegrade flow. It should therefore be understood that the modular endoprosthesis system 200 is configured such that blood flow therethrough can be antegrade in a first region and retrograde in a second region.
[0122] 14 shows a flow chart outlining another exemplary method for delivering a modular endoprosthesis of the present disclosure. In steps 14002 and 14004, a first guidewire and a second guidewire are placed in a branch vessel and a main vessel, respectively. In some instances, the first guidewire is placed in the branch vessel before the second guidewire is placed in the main vessel, and in other instances, the first guidewire is placed in the branch vessel after the second guidewire is placed in the main vessel. FIG. 15 shows a first guidewire and a second guidewire 1000 and 1050 placed in a branch vessel and a main vessel 104 and 100, respectively.
[0123] 14, in steps 14006 and 14008, the main vessel expandable component is advanced along the second guidewire 1050 to a position within the main vessel and then deployed once properly positioned. In some instances, steps 14006 and 14008 correspond to steps 8008 and 8010. Thus, as explained above, in various instances, proper positioning of the main vessel expandable component includes positioning the main vessel expandable component such that an end of the main vessel expandable component lands on or otherwise engages the main vessel upstream of the branch vessel, such that the branch vessel expandable component does not interfere with the end of the main vessel expandable component engaging the vessel wall or tissue surrounding the end of the main vessel expandable component, thereby allowing the main vessel expandable component to seal against the main vessel wall without interference from the other expandable components. 16 shows the main vessel expandable device 300 deployed within the main vessel 100 such that the proximal end 312 of the main vessel expandable device 300 engages the vessel wall of the main vessel upstream of the branch vessel 104 (see, e.g., the discussion above regarding deployment of the main vessel expandable device 300). Additionally, as shown in FIG 16, the distal end 314 of the main vessel expandable component 300 is positioned downstream of the branch vessel 104. The proximal end 312 of the main vessel expandable device 300 can use known means of engaging the vessel wall of the main vessel including anchors such as barbs.
[0124] Referring again to FIG. 14, in step 14010, the portal-expandable component is advanced along the first and second guidewires 1000 and 1050, respectively, until it is properly positioned within the main vessel relative to the main vessel expandable device. FIG. 17 illustrates the portal-expandable component 500 (hidden from view in FIG. 17 by the restraining sheath 1200) in a constrained, compacted delivery configuration consistent with the discussion above. As shown, the portal-expandable component 500 is advanced along the first and second guidewires 1000 and 1050, where the first guidewire 1000 extends through the portal 516 (hidden from view in FIG. 17 by the restraining sheath 1200) and the lumen of the portal-expandable component 500. In the example illustrated in FIG. 17, the first guidewire 1000 extends through a removable guidewire tube 1100 that extends through the portal and lumen of the portal-expandable component 500. However, as noted above, a removable guidewire tube is not necessary and is therefore optional and not required. Further, the second guidewire 1050 does not extend through the portal 516, but rather through a lumen of the portal-expandable component 500 (e.g., extends through a lumen from the first end 506 to the second end 508 of the portal-expandable component 500).
[0125] Referring again to FIG. 14, in step 14012, once properly positioned, the portal expandable component is deployed such that the portal expandable component is fluidly coupled with the main vessel expandable component. FIG. 18 shows that the portal expandable component 500 is deployed, the portal expandable component 500 is fluidly coupled with the main vessel expandable component 300, and the portal 516 is positioned downstream of the branch vessel 104. The portal expandable component 500 is deployed and coupled with the main vessel expandable component 300 consistent with the discussion above (see, e.g., the discussion regarding FIGS. 9E and 11). Additionally, as shown in FIG. 18, the first guidewire 1000 extends into the lumen of the portal expandable component 500 and through the portal 516 into the branch vessel 104.
[0126] In some instances, after the portal-expandable component 500 has been deployed, the removable guidewire tube 1100 can be removed from the portal-expandable component 500 along with the first guidewire 1000, leaving the first guidewire for future use, as described in more detail below. Alternatively, in some instances, the removable guidewire tube 1100 can be removed after loading the portal-expandable component 500 onto the first guidewire 1000 and prior to advancing the portal-expandable component 500 into the patient's vasculature (e.g., used for pre-cannulation only). That is, the removable guidewire tube 1100 can be used to load the portal-expandable component 500 and its delivery member onto the first guidewire 1000, but can be removed prior to advancing it within the patient's vasculature. In some instances, the removable guidewire tube 1100 can be removed by the physician by grasping the second end 1104 and pulling the removable guidewire tube 1100 in the opposite direction (e.g., distal to the lower access site) to advance the removable guidewire tube 1100 within the vascular system.
[0127] Referring again to FIG. 14, in step 14014, the branch vessel expandable component is advanced along the first guidewire until it is properly positioned relative to the portal expandable component and the branch vessel. In various examples, the branch vessel expandable component is advanced while being maintained in a constrained, collapsed delivery configuration (see discussion above). Furthermore, in various examples, proper positioning of the branch vessel includes positioning the branch vessel expandable component such that upon deployment, the branch vessel expandable component engages the branch vessel and the portal expandable component, thereby fluidly coupling the branch vessel and the portal expandable component together. FIG. 19 illustrates the branch vessel expandable component 400 being advanced along the first guidewire 1000. As shown, the branch vessel expandable component 400 (hidden from view by the constraining sheath 1210) is coupled with a delivery catheter 1220 advanced along the first guidewire 1000 to the illustrated position, such that the branch vessel expandable component 400 may be deployed, at least in part, within the branch vessel. Conventional fluoroscopy techniques utilizing radiopaque markers on any one or more components and / or delivery members of modular endoprosthesis system 200 can be used to facilitate placement of the various expandable components of modular endoprosthesis system 200 at the treatment site. For example, radiopaque markers can be placed at or near the ends of the expandable components, and / or at or near the portals of the portal expandable components 500, and / or at or near or along the legs of the branch endoprosthesis, and / or anywhere along the delivery members to facilitate orientation and relative positioning between the expandable components of modular endoprosthesis system 200 and the region of the patient's anatomy being treated. It should be understood that radiopaque markers can be utilized on any of the components discussed herein.
[0128] Referring again to FIG. 14, in step 14016, with the branch vessel expandable component properly positioned relative to the branch vessel 104 and the portal expandable component 500, the branch vessel expandable component is deployed such that the branch vessel is fluidly coupled to the portal expandable component 500 via the branch vessel expandable component 400. FIG. 20 shows the branch vessel expandable component 400 in a fully deployed configuration, where the branch vessel is fluidly coupled to the portal expandable component 500. Thus, the branch vessel 104 can be supplied with blood flowing through the modular endoprosthesis by retrograde flow through the branch vessel expandable component 400. That is, the branch vessel expandable component 400 allows blood flowing through the main vessel expandable component 300 to enter the branch vessel 104 by flowing into the portal expandable component 500 and then into the branch vessel expandable component 400, where blood flow through the portal expandable component 500 is antegrade flow and blood flow through the branch vessel expandable component 400 is retrograde flow. As described above, in addition to or as an alternative to perfusion into the renal artery 104, perfusion into the other renal artery 106 (see, e.g., FIG. 2 ) may be achieved via a second (or additional) portal expandable component 500 and a second (or additional) branch vessel expandable component 400, and optionally a bridge expandable component 600, where delivery and deployment of such components is consistent with the description above, but for accessing and deploying within the branch vessel 106 instead of the branch vessel 104.
[0129] In various examples, catheters, introducer sheaths, hubs, handles, and other components usable in the systems and methods referred to and disclosed herein can be constructed using any suitable medical grade material or combination of materials using any suitable manufacturing process or tooling. Suitable medical grade materials can include, for example, nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, polytetrafluoroethylene, expanded polytetrafluoroethylene, polytrifluorochloroethylene, polyvinyl chloride, polyurethane, elastomeric organosilicon polymers, Pebax® polyether block amide, and metals such as stainless steel and Nitinol. Catheters can also include a reinforcing member, such as a layer of metal braid.
[0130] It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents. (Aspect) (Aspect 1) providing a first expandable device configured to be deployed in a main blood vessel; providing a second expandable device configured to interface with the first expandable device, the second expandable device including a portal therein; providing a branch vessel expandable device configured to, once expanded, form a fluid connection between the branch vessel and the second expandable device through the portal; placing a branch guidewire into the branch vessel; placing the branch vessel expandable device over the branch guidewire and into the branch vessel while the branch vessel expandable device is maintained in a fully undeployed state; positioning and deploying the first expandable device within the main vessel; positioning and deploying the second expandable device downstream of the branch vessel; and deploying the branch vessel expandable device such that the branch vessel expandable device is fluidly coupled with the second expandable device through the portal of the second expandable device; Including, the branch vessel expandable device is disposed external to the first expandable device; the branched guidewire and the branched vascular expandable device each extend through a portal of the second expandable device; Blood is perfused into the branch vessel via retrograde flow. method. (Aspect 2) The method of embodiment 1, wherein the branch guidewire is placed within a renal artery, the branch vasculature expandable device is placed within the renal artery over the branch guidewire while being maintained in a fully undeployed state, the first expandable device is placed within the patient's aorta and deployed, the branch vasculature expandable device is positioned external to the first expandable device, the second expandable device is placed and deployed at least partially downstream of the renal artery, and the branch guidewire and branch expandable device extend through a portal to form a fluid connection between the renal artery and the second expandable device to provide retrograde perfusion of blood to the renal artery. (Aspect 3) 2. The method of embodiment 1, wherein the main vessel is a common iliac artery and the branch vessel is an internal iliac artery. (Aspect 4) 2. The method of embodiment 1, wherein the main vessel is the external iliac artery and the branch vessel is the femoral artery. (Aspect 5) 2. The method of any one of the preceding aspects, wherein positioning the branch vessel expandable device over the branch guidewire in the branch vessel comprises advancing the branch vessel expandable device over the branch guidewire after the second expandable device is deployed. (Aspect 6) The method of embodiment 5, wherein the branched vessel expandable device is deployed after the second expandable device is deployed. (Aspect 7) 2. The method of any one of the preceding aspects, wherein the branched vessel expandable device is directly coupled to the second expandable device. (Aspect 8) providing a first expandable device configured to be deployed within a blood vessel; providing a second expandable device configured to interface with the first expandable device, the second expandable device including a portal therein; providing a branch expandable device configured to form a fluid connection between the branch vessel and the second expandable device through the portal; placing a branched guidewire within the branched vessel; positioning and deploying the first expandable device within the main vessel; positioning and deploying the second expandable device downstream of the branch vessel; placing the branch expandable device over the branch guidewire to interconnect the branch vessel with the second expandable device external to the first expandable device; and deploying the branch expandable device to form a fluid connection between the branch vessel and the second expandable device; Including, the bifurcated guidewire extends through the portal; Blood is perfused into the branch vessel via retrograde flow. method. (Aspect 9) The method of embodiment 8, wherein the branched guidewire is positioned within the renal artery and the second expandable device is positioned and deployed at least partially downstream of the renal artery, the second expandable device being fluidly coupled to the renal artery via the branched expandable device to provide retrograde perfusion of blood to the renal artery. (Aspect 10) The method of embodiment 8, wherein the main vessel is a common iliac artery and the branch vessel is an internal iliac artery. (Aspect 11) The method of embodiment 8, wherein said main vessel is the external iliac artery and said branch vessel is the femoral artery. (Aspect 12) The method of any one of aspects 8-11, further comprising deploying a third expandable device between the second expandable device and the branch vessel expandable device. (Aspect 13) 13. The method of embodiment 12, wherein the third expandable device is advanced into position over the branched guidewire. (Aspect 14) 14. The method of any one of aspects 12 and 13, wherein the third expandable device is deployed after the branch vessel expandable device is deployed and after the second expandable device is deployed. (Aspect 15) The method of any one of the preceding aspects, wherein the second expandable device is provided in a collapsed delivery configuration and a removable guidewire tube extends through the portal to enable insertion of the branched guidewire therethrough. (Aspect 16) The method of embodiment 15, further comprising removing the removable guidewire tube after inserting the second guidewire through the removable guidewire tube. (Aspect 17) 17. The method of embodiment 16, further comprising removing the removable guidewire tube prior to inserting the second expandable device into the main vessel. (Aspect 18) 2. The method of any one of the preceding aspects, wherein the first expandable device and the second expandable device are deployed prior to deploying the branch vessel expandable device. (Aspect 19) The method of any one of aspects 8-17, wherein the branched vessel expandable device is deployed before the second expandable device is deployed. (Aspect 20) The method of any one of the preceding claims, wherein the branched vessel expandable device is deployed after the second expandable device is deployed. (Aspect 21) The method of any one of the preceding aspects, wherein the second expandable device is deployed after the first expandable device is deployed. (Aspect 22) 2. The method of any one of the preceding aspects, wherein each of the first expandable device, the second expandable device, and the branch expandable device are advanced from a first access site downstream of the branch vessel. (Aspect 23) 2. The method of any one of the preceding aspects, wherein the branched vessel expandable device is fluidly coupled to the second expandable device through the portal. (Aspect 24) The method of any one of the preceding aspects, wherein the first expandable device is advanced over a separate first guidewire that is distinct from the branched guidewire. (Aspect 25) 25. The method of embodiment 24, wherein the second expandable device is advanced over each of the first guidewire and the branch guidewire. (Aspect 26) The method of any one of the preceding aspects, wherein the portal is disposed in a sidewall of the second expandable device. (Aspect 27) 1. An expandable device configured to repair a main blood vessel extending from an upstream end to a downstream end, comprising: a first expandable device configured to be deployed within a blood vessel; a second expandable device configured to interface with the first expandable device, the second expandable device including a portal in a sidewall of the second expandable device; and a branch vessel expandable device configured to extend through the portal to form a fluid connection between the branch vessel and the second expandable device; Including, An expandable device, wherein the branch expandable device is configured to have a length sufficient to cooperate with the second expandable device implanted downstream of the branch blood vessel to enable retrograde perfusion into the branch blood vessel through the branch blood vessel expandable device. (Aspect 28) The expandable device of embodiment 27, wherein the branch vessel expandable device is configured to have sufficient radial expansion force to maintain significant flow therethrough when deployed outside of the first expandable device between the first expandable device and the wall of the main vessel. (Aspect 29) The expandable device of any one of embodiments 27 to 28, wherein the branched vessel expandable device is directly coupled to the second expandable device. (Aspect 30) 29. The expandable device of any one of aspects 27-28, further comprising a third expandable device extending between the second expandable device and the branch vessel expandable device, the third expandable device configured to enable retrograde perfusion to the branch vessel through the branch vessel expandable device and the third expandable device. (Aspect 31) The expandable device of any one of embodiments 27 to 30, wherein a sidewall of the second expandable device includes a recessed portion recessed relative to the sidewall, and the portal is located in the recessed portion. (Aspect 32) The expandable device of any one of aspects 27-30, further comprising a downstream expandable device extending from the second expandable component to fluidly couple the second expandable component to one or more blood vessels downstream of the second expandable component. (Aspect 33) The expandable device of any one of aspects 27 to 30, wherein the first expandable device includes a body portion, a first leg and a second leg branching from the body portion, and the second expandable device is configured to interface with one of the first leg and the second leg of the first expandable device. (Aspect 34) 34. The expandable device of embodiment 33, wherein the first leg and the second leg are structurally biased at an angle away from each other. (Aspect 35) The expandable device of any one of aspects 33 to 34, wherein the second expandable device is configured to interface with a first second leg of the first expandable device and further comprises an additional second expandable device, the additional second expandable device is configured to interface with a second leg of the first expandable device and comprises a portal in a side wall of the second expandable device. (Aspect 36) The expandable device of embodiment 35, further comprising an additional branch vessel expandable device configured to extend through the portal to form a fluid connection between a second branch vessel and the additional second expandable device. (Aspect 37) The expandable device of any one of aspects 27-36, wherein the second expandable component includes a proximal end and a distal end, and a tapered configuration, the proximal end having a smaller diameter than the distal end. (Aspect 38) The expandable device of any one of aspects 27 to 37, wherein the portal of the second expandable device is an aperture in a sidewall of the second expandable device. (Aspect 39) The expandable device of any one of aspects 27-38, further comprising a bridge expandable component configured to be disposed between the second expandable device and the first expandable device. (Aspect 40) The expandable device of embodiment 39, wherein the bridge expandable component is configured to expand with a first end coupled to the portal of the second expandable component and a second end coupled to the second expandable device component. (Aspect 41) The expandable device of embodiment 40, wherein the branched vascular expandable component comprises one or more tissue anchors for engaging tissue.
Claims
1. 1. An expandable device configured to repair a main blood vessel extending from an upstream end to a downstream end, comprising: a first expandable component configured to be deployed within a vessel; a second expandable component configured to interface with the first expandable component and including a sidewall including a recessed portion recessed relative to the sidewall, the recessed portion including a portal including an aperture reinforced by at least one support wall having at least one stent incorporated therein; and a branch vessel expandable component configured to extend through the portal to form a fluid connection between the branch vessel and the second expandable component; Including, An expandable device, wherein the branch vessel expandable component is configured to have a length sufficient to cooperate with the second expandable component implanted downstream of the branch vessel to enable retrograde perfusion into the branch vessel through the branch vessel expandable component.
2. The expandable device of claim 1 , wherein the branch vessel expandable component is configured to have sufficient radial expansion force to maintain significant flow therethrough when deployed outside of the first expandable component between the first expandable component and the wall of the main vessel.
3. The expandable device of any one of claims 1 to 2, wherein the branched vascular expandable component is directly coupled to the second expandable component.
4. The expandable device of any one of claims 1 to 2, further comprising a bridge expandable component extending between the second expandable component and the branch vessel expandable component, the bridge expandable component configured to enable retrograde perfusion through the branch vessel expandable component and the bridge expandable component to the branch vessel.
5. The expandable device of any one of claims 1 to 3, further comprising a downstream expandable component extending from the second expandable component to fluidly couple the second expandable component to one or more blood vessels downstream of the second expandable component.
6. The expandable device of any one of claims 1 to 3, wherein the first expandable component includes a body portion, a first leg and a second leg branching from the body portion, and the second expandable component is configured to interface with one of the first leg and the second leg of the first expandable component.
7. The expandable device of claim 6 , wherein the first leg and the second leg are structurally biased at an angle away from each other.
8. The expandable device of any one of claims 6 to 7, wherein the second expandable component is configured to interface with a first leg of the first expandable component, and further comprises an additional second expandable component, the additional second expandable component is configured to interface with a second leg of the first expandable component, and comprises a portal in a side wall of the second expandable component.
9. The expandable device of claim 8 , further comprising an additional branch vessel expandable component configured to extend through the portal to form a fluid connection between a second branch vessel and the additional second expandable component.
10. The expandable device of any one of claims 1 to 9, wherein the second expandable component includes a proximal end and a distal end, and a tapered configuration in which the proximal end has a smaller diameter than the distal end.
11. The expandable device of any one of claims 1 to 10, further comprising a bridge expandable component configured to be positioned between the second expandable component and the branch vessel expandable component.
12. The expandable device of claim 11 , wherein the bridge expandable component is configured to deploy with a first end coupled to a portal of the second expandable component and a second end coupled to the branch vessel expandable component.
13. The expandable device of claim 12 , wherein the branched vascular expandable component includes one or more tissue anchors for engaging tissue.
Citation Information
Patent Citations
Intraluminal prostheses with lateral branching and methods for transporting them
JP2010524629A
Branched stent graft device and deployment
JP2014526929A
Fenestrated inflatable graft
US20130103135A1
Device for repairing aneurysm within multi-branch vessel
US20170135806A1
Iliac branch device and method
US20170296324A1
